Dianthus Therapeutics, Inc.
DNTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001690585
In the last 90 days, Dianthus Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 269 institutions reported holding it in 13F filings for Q2 2026, worth $6.40B in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Dianthus Therapeutics, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 269
- +30 vs. Q1 2026
- Shares held
- 65.8M
- +3.55M (+5.7%) vs. Q1 2026
- Total value
- $6.40B
- +$1.22B (+23.5%) vs. Q1 2026
- New holders
- 63
- 116 more added
- Sold out
- 33
- 68 more reduced
2 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting DNTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 269 | $6.40B |
| Q1 2026 | 241 | $5.18B |
| Q4 2025 | 166 | $2.02B |
| Q3 2025 | 140 | $1.84B |
| Q2 2025 | 103 | $728.6M |
| Q1 2025 | 99 | $685.5M |
| Q4 2024 | 96 | $765.7M |
| Q3 2024 | 91 | $858.7M |
| Q2 2024 | 74 | $768.8M |
| Q1 2024 | 76 | $782.3M |
| Q4 2023 | 39 | $106.5M |
| Q3 2023 | 30 | $136.3M |
| Q2 2023 | 46 | $22.0M |
| Q1 2023 | 52 | $23.6M |
| Q4 2022 | 54 | $11.1M |
| Q3 2022 | 72 | $65.8M |
| Q2 2022 | 75 | $54.6M |
| Q1 2022 | 93 | $138.9M |
| Q4 2021 | 94 | $211.4M |
| Q3 2021 | 93 | $276.0M |
| Q2 2021 | 97 | $366.3M |
| Q1 2021 | 90 | $418.4M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Dianthus Therapeutics, Inc.; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Alyeska Investment Group, L.P. | 150,592 | $14.7M | 0.04% | +98,345+188.2% | Added |
| Neuberger Berman Group LLC | 157,574 | $15.4M | 0.01% | +98,498+166.7% | Added |
| Balyasny Asset Management LLC | 162,005 | $15.8M | 0.03% | −312,080−65.8% | Reduced |
| Artia Global Partners LP | 162,990 | $15.9M | 3.02% | 00.0% | Unchanged |
| Atika Capital Management LLC | 165,000 | $16.1M | 1.60% | +36,200+28.1% | Added |
| TimesSquare Capital Management, LLC | 166,357 | $16.2M | 0.24% | +166,357 | New |
| Ensign Peak Advisors, Inc | 174,187 | $17.0M | 0.03% | −30,149−14.8% | Reduced |
| Adage Capital Partners GP, L.L.C. | 185,000 | $18.0M | 0.03% | +25,000+15.6% | Added |
| Nicholas Investment Partners, LP | 186,769 | $18.2M | 1.03% | +135,519+264.4% | Added |
| Samlyn Capital, LLC | 196,326 | $19.1M | 0.32% | −234,789−54.5% | Reduced |
| Qube Research & Technologies Ltd | 196,924 | $19.2M | 0.02% | +166,570+548.8% | Added |
| StemPoint Capital LP | 200,851 | $19.6M | 3.39% | +115,349+134.9% | Added |
| Candriam Luxembourg S.C.A. | 204,214 | $19.9M | 0.09% | −9,308−4.4% | Reduced |
| LMR Partners LLP | 223,995 | $21.8M | 0.16% | +107,551+92.4% | Added |
| Eventide Asset Management, LLC | 225,261 | $22.0M | 0.29% | 00.0% | Unchanged |
| TD Asset Management Inc | 225,334 | $22.0M | 0.02% | +108,758+93.3% | Added |
| Pictet Asset Management Holding SA | 247,295 | $24.1M | 0.02% | +242,371+4,922.2% | Added |
| Emerald Advisers, LLC | 247,805 | $24.2M | 0.57% | +247,805 | New |
| RTW Investments, LP | 248,063 | $24.2M | 0.21% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 256,393 | $25.0M | 0.00% | +67,981+36.1% | Added |
| Bank of America Corp | 256,833 | $25.0M | 0.00% | +68,054+36.0% | Added |
| Artisan Partners Limited Partnership | 258,269 | $25.2M | 0.04% | −123,852−32.4% | Reduced |
| Tang Capital Management LLC | 264,692 | $25.8M | 1.17% | 00.0% | Unchanged |
| Assenagon Asset Management S.A. | 280,649 | $27.4M | 0.04% | +280,649 | New |
| First Turn Management, LLC | 285,771 | $27.9M | 2.98% | +64,850+29.4% | Added |
| Driehaus Capital Management LLC | 295,266 | $28.8M | 0.17% | −22,046−6.9% | Reduced |
| Vanguard Fiduciary Trust Co | 302,482 | $29.5M | 0.01% | +52,803+21.1% | Added |
| Westfield Capital Management Co LP | 314,914 | $30.7M | 0.10% | +314,914 | New |
| Dimensional Fund Advisors LP | 321,503 | $31.3M | 0.01% | −3,937−1.2% | Reduced |
| Vivo Capital, LLC | 353,998 | $34.5M | 3.15% | 00.0% | Unchanged |
| Spruce Street Capital LP | 354,816 | $34.6M | 6.79% | −18,458−4.9% | Reduced |
| Bain Capital Life Sciences Investors, LLC | 362,470 | $35.3M | 2.10% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 365,963 | $35.7M | 0.00% | +60,523+19.8% | Added |
| Goldman Sachs Group Inc | 382,161 | $37.3M | 0.00% | −165,849−30.3% | Reduced |
| Silverarc Capital Management, LLC | 390,000 | $38.0M | 4.23% | −264,746−40.4% | Reduced |
| Affinity Asset Advisors, LLC | 400,000 | $39.0M | 1.91% | +50,000+14.3% | Added |
| Northern Trust Corp | 411,791 | $40.1M | 0.00% | +108,039+35.6% | Added |
| MPM Oncology Impact Management LP | 420,002 | $40.9M | 2.50% | −3,980−0.9% | Reduced |
| Lord, Abbett & Co. LLC | 422,185 | $41.2M | 0.12% | +122,975+41.1% | Added |
| Barclays PLC | 431,753 | $42.1M | 0.01% | +52,147+13.7% | Added |
| Woodline Partners LP | 500,548 | $48.8M | 0.15% | +67,091+15.5% | Added |
| Ameriprise Financial Inc | 531,999 | $51.9M | 0.01% | +102,872+24.0% | Added |
| Vanguard Portfolio Management LLC | 570,115 | $55.6M | 0.00% | +220,734+63.2% | Added |
| Braidwell LP | 594,562 | $58.0M | 2.14% | −304,802−33.9% | Reduced |
| Alliancebernstein L.P. | 834,150 | $70.0M | 0.02% | −91,921−9.9% | Reduced |
| Cormorant Asset Management, LP | 750,000 | $73.1M | 3.75% | −200,000−21.1% | Reduced |
| Logos Global Management LP | 800,000 | $78.0M | 3.36% | +400,000+100.0% | Added |
| Baker Bros. Advisors LP | 852,164 | $83.1M | 0.42% | 00.0% | Unchanged |
| Franklin Resources Inc | 968,983 | $94.5M | 0.02% | +801+0.1% | Added |
| Citadel Advisors LLC | 974,911 | $95.0M | 0.05% | −635,572−39.5% | Reduced |
| Polar Capital Holdings Plc | 1,018,726 | $99.3M | 0.28% | −57,283−5.3% | Reduced |
| Jennison Associates LLC | 1,021,763 | $99.6M | 0.06% | +536,627+110.6% | Added |
| Deerfield Management Company, L.P. (Series C) | 1,125,313 | $109.7M | 1.14% | +105,500+10.3% | Added |
| UBS Group AG | 1,140,260 | $111.2M | 0.02% | +358,978+45.9% | Added |
| VR Adviser, LLC | 1,180,000 | $115.0M | 3.49% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 1,258,502 | $122.7M | 0.01% | +342,291+37.4% | Added |
| Fred Alger Management, LLC | 1,302,493 | $127.0M | 0.42% | +140,570+12.1% | Added |
| TCG Crossover Management, LLC | 1,676,624 | $163.4M | 3.93% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 1,841,667 | $179.5M | 16.48% | −105,000−5.4% | Reduced |
| Avidity Partners Management LP | 2,104,184 | $205.1M | 32.85% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 2,159,568 | $210.5M | 0.00% | +128,319+6.3% | Added |
| State Street Corp | 2,357,440 | $229.8M | 0.01% | +958,527+68.5% | Added |
| Price T Rowe Associates Inc | 2,514,946 | $245.2M | 0.02% | +1,367,998+119.3% | Added |
| Fairmount Funds Management LLC | 2,537,191 | $247.3M | 16.35% | 00.0% | Unchanged |
| Wellington Management Group LLP | 3,229,882 | $314.8M | 0.05% | +634,099+24.4% | Added |
| T. Rowe Price Investment Management, Inc. | 3,888,456 | $379.0M | 0.25% | +2,596,274+200.9% | Added |
| BlackRock, Inc. | 4,123,822 | $402.0M | 0.01% | +948,119+29.9% | Added |
| FMR LLC | 8,199,893 | $799.3M | 0.03% | +432,207+5.6% | Added |
| ABS Investment Management LLC | 97 | – | – | +97 | New |
| Ra Capital Management, L.P. | 0 | $0 | 0.00% | −2,611,733−100.0% | Sold out |
| Farallon Capital Management, L.L.C. | 0 | $0 | 0.00% | −836,000−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −643,599−100.0% | Sold out |
| Freestone Grove Partners LP | 0 | $0 | 0.00% | −239,943−100.0% | Sold out |
| Integral Health Asset Management, LLC | 0 | $0 | 0.00% | −150,000−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −85,530−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −67,282−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −55,000−100.0% | Sold out |
| Evergreen Quality Fund GP, Ltd. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −38,738−100.0% | Sold out |
| DV Trading LLC | 0 | $0 | 0.00% | −26,551−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −17,357−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −13,047−100.0% | Sold out |
| Lisanti Capital Growth, LLC | 0 | $0 | 0.00% | −12,410−100.0% | Sold out |
| Diadema Partners LP | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −7,716−100.0% | Sold out |
| Dymon Asia Capital (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −7,600−100.0% | Sold out |
| Polymer Capital Management (US) LLC | 0 | $0 | 0.00% | −7,339−100.0% | Sold out |
| Fieldview Capital Management, LLC | 0 | $0 | 0.00% | −5,973−100.0% | Sold out |
| Cannon Global Investment Management, LLC | 0 | $0 | 0.00% | −5,100−100.0% | Sold out |
| Twinbeech Capital LP | 0 | $0 | 0.00% | −4,831−100.0% | Sold out |
| RWC Asset Management LLP | 0 | $0 | 0.00% | −4,646−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −3,837−100.0% | Sold out |
| PEAK6 LLC | 0 | $0 | 0.00% | −2,925−100.0% | Sold out |
| Landscape Capital Management, L.L.C. | 0 | $0 | 0.00% | −2,540−100.0% | Sold out |
| 49 Wealth Management, LLC | 0 | $0 | 0.00% | −2,513−100.0% | Sold out |
| Chung Wu Investment Group, LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| ABS Direct Equity Fund LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Caitong International Asset Management Co., Ltd | 0 | $0 | 0.00% | −1,476−100.0% | Sold out |
| Advisory Services Network, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| MAI Capital Management | 0 | $0 | 0.00% | −18−100.0% | Sold out |